Karriereverlauf von Paul van Slyke
Ehemalige bekannte Positionen von Paul van Slyke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHARMADRUG INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.05.2021 | 01.05.2023 |
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Paul van Slyke
| University of Toronto | Doctorate Degree |
Statistik
International
| Kanada | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMADRUG INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Health Technology |
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Health Technology |
- Börse
- Insiders
- Paul van Slyke
- Erfahrung
